Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Organic & Biomolecular Chemistry|January 24, 2015
Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactionsFabio Doro, Cinzia Colombo, Chiara Alberti, et al.
Science Immunology|July 24, 2021
Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulationLesly Calderón, Karina Schindler, Stephen G Malin, et al.
Recenti Progressi in Medicina|November 16, 2021
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]Claudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Journal of Clinical Medicine|February 13, 2025
Facial Nerve Graft in Malignant Tumors: The Role of Facial RehabilitationFrancesco Mattioli, Costanza Galloni, Chiara Alberti, et al.
Cell Reports. Medicine|July 16, 2026
Alterations of the host-lung microbiome metasystem in systemic inflammatory response syndrome is associated with secondary pneumoniaDebajyoti Sinha, Melanie Petrier, Florian Pierre Martin, et al.
Science Translational Medicine|October 8, 2025
Immune signatures link myelin oligodendrocyte glycoprotein antibody-associated disease to other autoantibody-mediated conditionsJonas Schmid, Chiara Alberti, Laura Power, et al.
The World Allergy Organization Journal|August 19, 2024
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approachMarco Caminati, Lucia Federica Carpagnano, Chiara Alberti, et al.
Immunity|May 29, 2021
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumoniaStefanie Kreutmair, Susanne Unger, Nicolás Gonzalo Núñez, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2022
Preexisting comorbidities shape the immune response associated with severe COVID-19Stefanie Kreutmair, Manuel Kauffmann, Susanne Unger, et al.
Expert Opinion on Biological Therapy|October 31, 2025
Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database networkFederica Soardo, Andrea Spini, Luca L'Abbate, et al.
Pageof 3